Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikkel Rohde

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cell Cycle (Georgetown, Tex.)|June 23, 2005
Hsp70-2 is required for tumor cell growth and survivalMads Daugaard, Marja Jäättelä, Mikkel Rohde
FEBS Letters|June 5, 2007
The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functionsMads Daugaard, Mikkel Rohde, Marja Jäättelä
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 13, 2012
A novel and rapid apoptosis assay based on thiol redox statusMette E Skindersoe, Mikkel Rohde, Soeren Kjaerulff
Clinical Chemistry|November 2, 2012
IsoPCR: an analytically sensitive, nested, multiplex nucleic acid amplification methodMartin Jensen Søe, Mikkel Rohde, Jens Mikkelsen, et al.
Cancer Chemotherapy and Pharmacology|April 12, 2011
Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulationCristina P R Xavier, Cristovao F Lima, Mikkel Rohde, et al.
Genes & Development|August 20, 2024
Corrigendum: Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanismsMikkel Rohde, Mads Daugaard, Mette Hartvig Jensen, et al.
Genes & Development|March 3, 2005
Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanismsMikkel Rohde, Mads Daugaard, Mette Hartvig Jensen, et al.
Molecular Cancer Therapeutics|July 10, 2019
Cell Death Induced by Cationic Amphiphilic Drugs Depends on Lysosomal Ca<sup>2+</sup> Release and Cyclic AMPAtul Anand, Bin Liu, Jano Dicroce Giacobini, et al.
BMC Urology|July 3, 2025
An example of drug repurposing: ebastine in combination with docetaxel as a treatment for metastatic castration-resistant prostate cancer-the EXUROC prostate study, a clinical trial protocolKatrine Ørum, Dag R Stormoen, Jakob Lauritsen, et al.
Cancer Research|December 25, 2002
Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletionJesper Nylandsted, Wolfgang Wick, Ulrich A Hirt, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|June 23, 2005
Hsp70-2 is required for tumor cell growth and survivalMads Daugaard, Marja Jäättelä, Mikkel Rohde
FEBS Letters|June 5, 2007
The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functionsMads Daugaard, Mikkel Rohde, Marja Jäättelä
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 13, 2012
A novel and rapid apoptosis assay based on thiol redox statusMette E Skindersoe, Mikkel Rohde, Soeren Kjaerulff
Clinical Chemistry|November 2, 2012
IsoPCR: an analytically sensitive, nested, multiplex nucleic acid amplification methodMartin Jensen Søe, Mikkel Rohde, Jens Mikkelsen, et al.
Cancer Chemotherapy and Pharmacology|April 12, 2011
Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulationCristina P R Xavier, Cristovao F Lima, Mikkel Rohde, et al.
Genes & Development|August 20, 2024
Corrigendum: Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanismsMikkel Rohde, Mads Daugaard, Mette Hartvig Jensen, et al.
Genes & Development|March 3, 2005
Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanismsMikkel Rohde, Mads Daugaard, Mette Hartvig Jensen, et al.
Molecular Cancer Therapeutics|July 10, 2019
Cell Death Induced by Cationic Amphiphilic Drugs Depends on Lysosomal Ca<sup>2+</sup> Release and Cyclic AMPAtul Anand, Bin Liu, Jano Dicroce Giacobini, et al.
BMC Urology|July 3, 2025
An example of drug repurposing: ebastine in combination with docetaxel as a treatment for metastatic castration-resistant prostate cancer-the EXUROC prostate study, a clinical trial protocolKatrine Ørum, Dag R Stormoen, Jakob Lauritsen, et al.
Cancer Research|December 25, 2002
Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletionJesper Nylandsted, Wolfgang Wick, Ulrich A Hirt, et al.
Pageof 2